Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | FBP1 | P09467 | 2/20 | 0.36 |
| ▸ | CPA1 | P15085 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL29163778 | 0.98 | NPC1 (0.42) | CES2CES1NPC1ADAM17ALDH1A1 | |
| SCHEMBL22559438 | 0.79 | ALDH1A1 (0.38) | NPC1ALDH1A1HPGDHIF1ACYP1A2 | |
| SCHEMBL1150553 | 0.78 | LMNA (0.44) | CES2CES1NPC1ADAM17ALDH1A1 | |
| SCHEMBL3626469 | 0.77 | ALDH1A1 (0.38) | NPC1ALDH1A1HPGDHIF1AKMT2A | |
| SCHEMBL22559530 | 0.77 | FBP1 (0.39) | ALDH1A1LMNAHPGDHIF1ACYP1A2 | |
| SCHEMBL7931350 | 0.77 | CYP1A2 (0.41) | CES2CES1NPC1ADAM17ALDH1A1 | |
| SCHEMBL3675454 | 0.76 | ALDH1A1 (0.35) | ALDH1A1HPGDHIF1A | |
| SCHEMBL8510918 | 0.75 | LMNA (0.46) | NPC1ADAM17ALDH1A1LMNAGSR | |
| SCHEMBL146897 | 0.75 | LMNA (0.46) | NPC1ADAM17ALDH1A1LMNAGSR | |
| SCHEMBL6281430 | 0.75 | LMNA (0.46) | NPC1ADAM17ALDH1A1LMNAGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 391 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111303102-B | Nitroreductase responsive hypoxic probe compound and preparation and application thereof | 福建医科大学孟超肝胆医院(福州市传染病医院) | 2022-10-25 | — | — | CN | claimed |
| CN-111943965-B | Pyridine imine derivative and 8-hydroxyquinoline derivative cadmium complex dye sensitizer (BDTT-im-Cd) and preparation method and application thereof | 湘潭大学 | 2022-09-06 | — | — | CN | claimed |
| WO-2021120653-A1 | COFACTOR-SUBSTRATE PROBE PLATFORM FOR FAST QUANTITATIVE DETECTION OF TUMOR HYPOXIA RELATED ENZYME | 大连理工大学 | 2021-06-24 | — | — | WO | claimed |
| WO-2021103700-A1 | NITROREDUCTASE RESPONSIVE HYPOXIA PROBE COMPOUND, AND PREPARATION AND APPLICATION THEREOF | 福建医科大学孟超肝胆医院 | 2021-06-03 | — | — | WO | claimed |
| CN-108084450-B | Polymerization complex containing vinylphenyl and p-vinylphenol methylamine derivative cadmium and preparation method and application thereof | 湘潭大学 | 2021-05-07 | — | — | CN | claimed |
| CN-111943965-A | Pyridine imine derivative and 8-hydroxyquinoline derivative cadmium complex dye sensitizer and preparation method and application thereof | 湘潭大学 | 2020-11-17 | — | — | CN | claimed |
| CN-111303102-A | Nitroreductase responsive hypoxic probe compound and preparation and application thereof | 福建医科大学孟超肝胆医院(福州市传染病医院) | 2020-06-19 | — | — | CN | claimed |
| CN-111019644-A | Rapid quantitative detection of tumor hypoxia related enzyme by using cofactor-substrate probe platform | 大连理工大学 | 2020-04-17 | — | — | CN | claimed |
| CN-110381854-A | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | 考恩特兰有限公司 | 2019-10-25 | — | — | CN | claimed |
| CN-102731518-B | O-nitro aryl methoxycamptothecine anoxic activated prodrug used for antitumor drug | JINAN TRIO PHARMACEUTICAL TECHNOLOGY CO LTD | 2014-12-03 | — | — | CN | claimed |
| CN-101747328-A | Synthesis method of single-ring imipenem p-nitro benzyl ester | HEZE RUICHANG CHEMICAL CO LTD | 2010-06-23 | — | — | CN | claimed |
| WO-2010052536-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PARA-NITROBENZYL BROMIDE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-05-14 | — | — | WO | claimed |
| US-7247652-B2 | β-benzyloxyaspartate derivatives with amino group on benzene ring | SUNTORY LIMITED (JP) | 2007-07-24 | — | — | US | claimed |
| US-20040242652-A1 | Beta benzyloxyaspartate derivatives with amino group on benzene ring | SUNTORY HOLDINGS LTD. (JP) | 2004-12-02 | — | — | US | claimed |
| WO-2004099288-A1 | POLYETHYLENEIMINE POLYMERS | CARLSBERG A/S (DK) | 2004-11-18 | — | — | WO | claimed |
| EP-1397370-A1 | B-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING | SUNTORY LIMITED (JP) | 2004-03-17 | — | — | EP | claimed |
| WO-2003000698-A1 | β-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING | SUNTORY LIMITED (JP) | 2003-01-03 | — | — | WO | claimed |
| US-5565602-A | REACTING A HYDROCARBYL CHLORIDE WITH A CARBONYL SULFIDE AND AMINE IN PRESENCE OF A BASIC CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1996-10-15 | — | — | US | claimed |
| EP-0296522-B1 | Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation | DOW CHEMICAL CO (US) | 1996-09-25 | — | — | EP | claimed |
| EP-0341066-A2 | Immunostimulating guanine derivatives, compositions and methods | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-11-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242652-A1 | Beta benzyloxyaspartate derivatives with amino group on benzene ring | SLC1A5, SLC1A1, SLC7A1 | CES2 2676/4885CES1 1431/4885NPC1 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.